Feroz Khan

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

Medicinal chemistry (Shariqah (United Arab Emirates))

Molecules (Basel, Switzerland)

Chemical biology & drug design

Scientific reports

Central Institute of Medicinal and Aromatic Plants CSIR

Institute of Engineering and Technology (UPTU) (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central Institute of Medicinal and Aromatic Plants CSIR Dec 04 2011

India

Senior Scientist :: Metabolic and Structural Biology

University of California San Diego Nov 07 2016 - Nov 06 2017

United States

Visiting Research Scientist (on deputation) :: Skaggs School of Pharmacy & Pharmaceutical Sciences

Central Institute of Medicinal and Aromatic Plants CSIR Dec 04 2007 - Dec 03 2011

India

Scientist :: Metabolic & Structural Biology

Education History

Institute of Engineering and Technology (UPTU) Mar 01 2004 - Jun 17 2009

India

PHD :: Bioinformatics

Publications

Meenakshi Verma, Aqib Sarfraz, Inamul Hasan, Prema Gauri Vasudev, Feroz Khan
Structure-Activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds. Medicinal chemistry (Shariqah (United Arab Emirates)) 20 (6) (2024)
Meenakshi Verma, Inamul Hasan, Feroz Khan, Prema Gauri Vasudev
Structure-activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds. Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)
Meenakshi Verma, Aqib Sarfraz, Inamul Hasan, Prema Gauri Vasudev, Feroz Khan
Structure-Activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds. Medicinal chemistry (Shariqah (United Arab Emirates)) 20 (6) (2024)
Meenakshi Verma, Aqib Sarfraz, Inamul Hasan, Prema Gauri Vasudev, Feroz Khan
Structure-activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds. Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)
Satyamvada Maurya, Amita Jain, Md Tabish Rehman, Ali Hakamy, Farkad Bantun, Mohamed F AlAjmi, Vineeta Singh, Aafreen Zehra, Feroz Khan, Shafiul Haque, Bhartendu Nath Mishra
In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules (Basel, Switzerland) 28 (4) (2023)
Satyamvada Maurya, Amita Jain, Md Tabish Rehman, Ali Hakamy, Farkad Bantun, Mohamed F AlAjmi, Vineeta Singh, Aafreen Zehra, Feroz Khan, Shafiul Haque, Bhartendu Nath Mishra
In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules (Basel, Switzerland) 28 (4) (2023)
Satyamvada Maurya, Amita Jain, Md Tabish Rehman, Ali Hakamy, Farkad Bantun, Mohamed F AlAjmi, Vineeta Singh, Aafreen Zehra, Feroz Khan, Shafiul Haque, Bhartendu Nath Mishra
In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules (Basel, Switzerland) 28 (4) (2023)
Satyamvada Maurya, Amita Jain, Md Tabish Rehman, Ali Hakamy, Farkad Bantun, Mohamed F AlAjmi, Vineeta Singh, Aafreen Zehra, Feroz Khan, Shafiul Haque, Bhartendu Nath Mishra
In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules (Basel, Switzerland) 28 (4) (2023)
Sadiya Khwaja, Kaneez Fatima, Divya Mishra, Vineet Babu, Yogesh Kumar, Sumera Banu Malik, Misbah Tabassum, Suaib Luqman, Dnyaneshwar U Bawankule, Debabrata Chanda, Feroz Khan, Dilip M Mondhe, Arvind S Negi
An improved synthesis of indanocine and antiproliferative activity of 2-benzylindanocine via microtubule destabilization. Chemical biology & drug design 98 (1) (2021)
Ankita Srivastava, Kusumoori Ravi, Kaneez Fatima, Mayank Maheshwari, Raghib Ashraf, Mohammad Hasanain, Pankaj Yadav, Hina Iqbal, Yogesh Kumar, Suaib Luqman, Debabrata Chanda, Feroz Khan, Karuna Shanker, Jayanta Sarkar, Arvind Singh Negi
3-Arylindanones and related compounds as antiproliferative agents against colorectal cancer. Chemical biology & drug design 94 (3) (2019)
Balakishan Bhukya, Kaneez Fatima, Abhishek Nagar, Vijaya Lakshmi, Poornima Dubey, Shailesh Kumar, Yogesh Kumar, Suaib Luqman, Debabrata Chanda, Sudeep Tandon, Karuna Shanker, Feroz Khan, Arvind Singh Negi
Brevifoliol ester induces apoptosis in prostate cancer cells by activation of caspase pathway. Chemical biology & drug design 95 (1) (2019)
Yogesh Kumar, Feroz Khan, Shubhra Rastogi, Ajit Kumar Shasany
Genome-wide detection of terpene synthase genes in holy basil (Ocimum sanctum L.). PloS one 13 (11) (2018)
Sarfaraz Alam, Feroz Khan
3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7. Scientific reports 7 (1) (2017)
Sarfaraz Alam, Feroz Khan
QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity. Journal of biomolecular structure & dynamics 36 (9) (2017)

Feroz Khan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Feroz Khan